Solved

Surrogate Endpoints for a Clinical Trial of a Drug to Control

Question 32

Multiple Choice

Surrogate endpoints for a clinical trial of a drug to control hypertension may include:


A) subclinical disease.
B) physical measures such as reduction in blood pressure.
C) occurrence of strokes and heart attacks.
D) subclinical disease and physical measures such as reduction in blood pressure.

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions